Tonawanda, NY – September 19, 2024 – Pine Pharmaceuticals is proud to announce the return of Epi-Caine (Epinephrine 0.025%–Lidocaine HCl 0.75%). Designed with convenience and efficiency in mind, Epi-Caine is packaged in a 1 mL single-use vial and offers an extended shelf life, making it a reliable solution for healthcare providers.
“Our team is thrilled to bring a product like Epi-Caine back to the market,” said James Ando, Pharm.D., Innovation & Development Manager. “We understand the importance of supplying dependable solutions and are committed to ensuring health systems have access to them.”
As an FDA-registered 503B outsourcing facility, Pine Pharmaceuticals upholds the highest standards of quality and integrity. Every product undergoes a strictly controlled preparation process, ensuring health systems have access to cost-effective, high-quality solutions that deliver exceptional patient care.
About Pine Pharmaceuticals LLC
Pine Pharmaceuticals is an FDA-registered 503B outsourcing facility that specializes in the preparation of high-quality, ready-to-administer compounds and repackaged products. As a best-in-class partner, Pine Pharmaceuticals is committed to meeting the FDA’s stringent cGMP requirements while supporting hospitals, surgery centers, and practices nationwide. For more information, please visit www.pinepharmaceuticals.com or call 844-218-4138 to learn more about our products and services.
©2025 Pine Pharmaceuticals. All rights reserved.